In one paragraphArticle in Journal of human immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
39 authors.
Horst von BernuthDepartment of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité University Medicine, Berlin, Corporate Member of Free University and Humboldt University and Berlin Institute of Health, Berlin, Germany.ORCID https://orcid.org/0000-0002-5812-7675 Lisa EhlersDepartment of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité University Medicine, Berlin, Corporate Member of Free University and Humboldt University and Berlin Institute of Health, Berlin, Germany.ORCID https://orcid.org/0000-0001-8737-001X Susan FarmandDivision of Pediatric Stem Cell Transplantation and Immunology, Department of Pediatric Hematology and Oncology, University Medical Center Hamburg, Hamburg, Germany.ORCID https://orcid.org/0000-0002-8441-1784 Elisabeth Förster-WaldlDivision of Neonatology, Department of Pediatrics and Adolescent Medicine, Intensive Care and Neuropediatrics, Center for Congenital Immunodeficiencies, Medical University of Vienna, Vienna, Austria.ORCID https://orcid.org/0000-0002-8484-9890 Sujal GhoshDepartment for Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Center of Child and Adolescent Health, Heinrich Heine University, Düsseldorf, Germany.ORCID https://orcid.org/0000-0001-5647-4262 Tilmann KallinichDepartment of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité University Medicine, Berlin, Corporate Member of Free University and Humboldt University and Berlin Institute of Health, Berlin, Germany.ORCID https://orcid.org/0000-0003-2404-9397 Lisa-Maria KuhnDepartment for Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Center of Child and Adolescent Health, Heinrich Heine University, Düsseldorf, Germany.ORCID https://orcid.org/0009-0007-2880-6320 Kai LehmbergDivision of Pediatric Stem Cell Transplantation and Immunology, Department of Pediatric Hematology and Oncology, University Medical Center Hamburg, Hamburg, Germany.ORCID https://orcid.org/0000-0003-2365-4341 Ingo MüllerDivision of Pediatric Stem Cell Transplantation and Immunology, Department of Pediatric Hematology and Oncology, University Medical Center Hamburg, Hamburg, Germany.ORCID https://orcid.org/0000-0002-7477-6632 Tim NiehuesCentre for Child and Adolescent Health, Helios Klinikum Krefeld, Affiliated with Rheinisch-Westfälische Technische Hochschule University Aachen, Aachen, Germany.ORCID https://orcid.org/0000-0002-9945-8833 Prasad T OommenDepartment for Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Center of Child and Adolescent Health, Heinrich Heine University, Düsseldorf, Germany.ORCID https://orcid.org/0000-0003-2893-7252 Jana Pachlopnik SchmidDivision of Immunology and Children's Research Center, University Children's Hospital Zurich, and Pediatric Immunology, Faculty of Medicine, University of Zurich, Zurich, Switzerland.ORCID https://orcid.org/0000-0002-6653-9047 Seraina PraderDivision of Immunology and Children's Research Center, University Children's Hospital Zurich, and Pediatric Immunology, Faculty of Medicine, University of Zurich, Zurich, Switzerland.ORCID https://orcid.org/0000-0002-2950-5411 Alexander PuzikDepartment of Pediatric Hematology, Oncology and Stem Cell Transplantation, Children's Hospital, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.ORCID https://orcid.org/0000-0003-1432-5183 Bodo GrimbacherInstitute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.ORCID https://orcid.org/0000-0002-6897-6806 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Deficiency of adenosine deaminase 2 (DADA2) is an autoinflammatory disease with diverse phenotypes. We describe the genetics, phenotypes, and treatment of
Identifiers
PMID42312136
PMCPMC13271008
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390